Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

astrazeneca_building_white_47

AstraZeneca reaches deal with RenalytixAI to develop medicine strategies for a variety of diseases

August 24, 2020 Sales and Marketing AI, chronic disease

AstraZeneca and RenalytixAI have agreed a deal to develop joint precision medicine strategies for cardiovascular, renal and metabolic diseases. The …
News
china_v

China’s ‘insect’ vaccine for COVID-19 approved for human testing

August 24, 2020 Sales and Marketing COVID, Vaccine, coronavirus

China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect …
News
remsss

Gilead says FDA could expand eligibility of coronavirus patients for remdesivir

August 24, 2020 Sales and Marketing FDA, Gilead

The FDA could expand its Emergency Use Authorization (EUA) for Gilead’s remdesivir for treating coronavirus patients, according to Gilead.
News
covidgenome

FDA approves Phase 1 trial for HIV gene therapy

August 24, 2020 Sales and Marketing CAR T, CAR T cancer therapies, CAR-T

The FDA has approved a request from American Gene Technologies to begin a clinical study into its HIV gene therapy. …
News
fda

FDA grants emergency authorisation for coronavirus plasma treatment

August 24, 2020 Sales and Marketing COVID-19, FDA, coronavirus

The FDA has issued an Emergency Use Authorization (EUA) for convalescent plasma to treat patients with COVID-19. The regulatory body …
News

AstraZeneca scores Japanese approval for Imfinzi combo in extensive-stage small cell lung cancer

August 21, 2020 Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, Japan

AstraZeneca’s Imfinzi (durvalumab) has secured approval in Japan for the treatment of extensive-stage small cell lung cancer when combined with etoposide and …
News
gilead-sciences

FDA turns down Gilead’s JAK inhibitor filgotinib in rheumatoid arthritis, endangering 2020 approval hopes

August 20, 2020 Research and Development, Sales and Marketing FDA, Gilead, filgotinib

Gilead’s JAK inhibitor filgotinib has been unexpectedly knocked back by the FDA as a therapy to treat moderately to severely …
News
biogen-idec-tecfidera-dimethyl-fumarate

Mylan secures first FDA approval for generic version of Biogen’s Tecfidera following patent dispute

August 20, 2020 Sales and Marketing Biogen, FDA, Mylan, generic, tecfidera

The FDA has approved its first generic of Biogen’s multiple sclerosis (MS) treatment Tecfidera, awarding authorisation to Mylan which is …
News
fda_21

FDA delays BioMarin’s gene therapy for haemophilia A

August 20, 2020 Research and Development, Sales and Marketing FDA

The FDA has delayed Roctavin, BioMarin’s gene therapy for haemophilia A, by a year to wait for more extensive results, …
News
madrid_-_johnson__johnson_1

Johnson & Johnson seals largest pharmaceutical merger of the year by purchasing Momenta for $6.5 billion

August 20, 2020 Business Services, Sales and Marketing Johnson and Johnson, Momenta

Johnson & Johnson is set to buy the Cambridge based Momenta Pharmaceuticals for $6.5 billion, making it the largest pharmaceutical …
News
shutterstock_273326141

Bristol Myers Squibb pays $475 million for exclusive rights to Dragonfly Therapeutics’ IL-12 immunotherapy programme

August 18, 2020 Manufacturing and Production, Sales and Marketing Bristol Myers Squib, Drgonfly Therapeutics, pharma, pharma deal

Bristol Myers Squibb has scooped up the sole rights to the interleukin-12 (IL-12) immunotherapy programme of Massachusetts-based biotech Dragonfly Therapeutics, …
News
shutterstock_36423250

China approves its first biosimilar of Roche’s Herceptin in HER2+ cancers

August 18, 2020 Manufacturing and Production, Sales and Marketing China, Henlius, Herceptin, Roche, biosimilar

China’s National Medical Products Administration (NMPA) has given the green light to Shanghai’s Henlius for its biosimilar version of Roche’s …
News
transportation_isolation_system

China’s drug regulator says vaccines must have 50 percent efficacy to be approved

August 17, 2020 Sales and Marketing COVID, China, coronavirus, vaccines

The Chinese Centre for Drug Evaluation (CCDE) has said that coronavirus vaccines must show 50 percent efficacy to be approved.  …
News
cokc

Public Health England set to be replaced by a new agency to specifically deal with pandemics

August 17, 2020 Sales and Marketing COVID, Public Health England, pandemic, phe

Public Health England is set to be replaced with a new agency to prepare the country to deal with future …
News
23814734268_1b63909bf3_z

Amazon Pharmacy launches in India

August 17, 2020 Sales and Marketing India, amazon, pharma

Amazon has entered the pharmaceutical market by launching ‘Amazon Pharmacy’ in India. 
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025